论文部分内容阅读
目的通过对肝癌患者凝血四项(PT、APTT、TT、FIB)的检测以了解肝癌患者的凝血功能情况。方法利用日本东亚CA-50血凝仪,检测67例肝癌患者及50例健康体检者的PT、APTT、TT.、FIB水平。结果肝癌患者的凝血四项指标与对照组比较PT、APTT、TT均明显延长,FIB明显下降,两者比较差异有统计学意义(P<0.01)。结论凝血四项指标可客观准确评价肝癌患者的凝血功能状况,为临床的治疗及疗效观察提供科学依据。
Objective To investigate the coagulation function of patients with hepatocellular carcinoma by detecting four coagulation (PT, APTT, TT, and FIB) of liver cancer patients. Methods The Japanese East Asia CA-50 blood coagulation apparatus was used to detect the levels of PT, APTT, TT, and FIB in 67 patients with liver cancer and 50 healthy persons. Results Compared with the control group, the PT, APTT and TT of liver cancer patients were significantly prolonged and the FIB was significantly decreased. There was a statistically significant difference between the two groups (P<0.01). Conclusion The four coagulation indexes can objectively and accurately evaluate the coagulation function of patients with liver cancer, and provide scientific basis for clinical treatment and observation of curative effect.